Suraksha Diagnostic Complete Financial Statements
In FY2025, Suraksha Diagnostic (SURAKSHA) reported revenue ₹80 Cr, net profit ₹9 Cr and EPS ₹1.73, with a net profit margin of 11.3% and ROE of 4.3%. Full financial statements from FY2020 to FY2025 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Suraksha Diagnostic share price chart.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
SURAKSHA Revenue, Net Profit & EBITDA — Year-on-Year Growth
SURAKSHA YoY (Sept 2024 vs Sept 2025) — revenue +17.6%, net profit -10.0%, expenses +25.0%.
SURAKSHA Income Statement — Revenue, EBITDA & Net Profit
Suraksha Diagnostic revenue ₹80 Cr, EBITDA ₹25 Cr, net profit ₹9 Cr, EPS ₹1.73 (2025) — net profit margin 11.3%. Explore Suraksha Diagnostic intrinsic price to estimate fundamental worth using multiple valuation models.
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Jun 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 80 | 66 | 74 | 78 | 68 | 56 | 62 | 60 | 61 | 53 | 53 |
| Expenses | 55 | 46 | 49 | 55 | 44 | 37 | 40 | 41 | 39 | 37 | 37 |
| EBITDA | 25 | 20 | 25 | 24 | 25 | 20 | 22 | 19 | 21 | 16 | 16 |
| Operating Profit Margin % | 31.00% | 29.00% | 33.00% | 30.00% | 35.00% | 34.00% | 34.00% | 31.00% | 35.00% | 28.00% | 30.00% |
| Depreciation | 10 | 9 | 10 | 11 | 9 | 8 | 9 | 9 | 8 | 8 | 8 |
| Interest | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 2 | 2 |
| Profit Before Tax | 12 | 9 | 13 | 10 | 14 | 9 | 11 | 8 | 11 | 5 | 6 |
| Tax | 3 | 2 | 3 | 3 | 4 | 3 | 3 | 2 | 3 | 1 | 2 |
| Net Profit | 9 | 7 | 9 | 7 | 10 | 6 | 8 | 6 | 8 | 4 | 5 |
| Earnings Per Share (₹) | 1.73 | 1.42 | 1.80 | 1.44 | 1.94 | 1.22 | 1.49 | 1.18 | 2.44 | 1.17 | 0.87 |
SURAKSHA Balance Sheet — Assets, Liabilities & Shareholders' Equity
SURAKSHA total assets ₹334 Cr, total equity ₹210 Cr, total liabilities ₹ Cr (2025) — ROE 4.3%.
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 334 | 300 | 281 | 0 | 171 | 173 |
| Current Assets | 47 | 72 | 68 | 0 | 27 | 28 |
| Fixed Assets | 223 | 212 | 195 | 0 | 119 | 128 |
| Capital Work in Progress | 11 | 1 | 2 | 0 | 0 | 0 |
| Investments | 1 | 0 | 0 | 0 | 5 | 5 |
| Other Assets | 99 | 87 | 84 | 0 | 47 | 39 |
| LIABILITIES | ||||||
| Total Liabilities | ||||||
| Current Liabilities | 81 | 82 | 87 | 0 | 20 | 19 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 210 | 179 | 156 | 0 | 126 | 120 |
| Share Capital | 10 | 9 | 9 | 0 | 9 | 9 |
| Reserves & Surplus | 201 | 171 | 147 | 0 | 118 | 111 |
SURAKSHA Cash Flow Statement — Operating, Investing & Financing
Suraksha Diagnostic operating cash flow ₹63 Cr, investing ₹-40 Cr, financing ₹-24 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|
| Operating Activities | 63 | 61 | 44 | 42 | 24 | 31 |
| Investing Activities | -40 | -35 | -21 | -44 | -28 | -20 |
| Financing Activities | -24 | -25 | -24 | 1 | 3 | -10 |
| Net Cash Flow | 0 | 0 | -1 | 0 | -1 | 1 |